• Home
  • Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC.

Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC.

Author List
Cheng ML, Lau CJ, Milan MSD, Supplee JG, Riess JW, Bradbury PA, Jänne PA, Oxnard GR, Paweletz CP
Publication
JCO precision oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/212334808
Publication Year
2021
PubMed ID
34250387
Publication Title
Cheng ML, Lau CJ, Milan MSD, Supplee JG, Riess JW, Bradbury PA, Jänne PA, Oxnard GR, Paweletz CP. Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC. JCO Precis Oncol. 2021; 5.